El rol de la investigación contable en la academia y sociedad

.Fundación Universitaria Los Libertadore

KITD816V mutation in blood for the diagnostic screening of systemic mastocytosis and mast cell activation syndromes

[Background]: Current diagnostic algorithms for systemic mastocytosis (SM) rely on the detection of KITD816V in blood to trigger subsequent bone marrow (BM) investigations. [Methods]: Here, we correlated the KITD816V mutational status of paired blood and BM samples from 368 adults diagnosed with mast cell activation syndrome (MCAS) and mastocytosis and determined the potential utility of investigating KITD816V in genomic DNA from blood-purified myeloid cell populations to increase diagnostic sensitivity. In a subset of 69 patients, we further evaluated the kinetics of the KITD816V cell burden during follow-up and its association with disease outcome. [Results]: Our results showed a high correlation (P < .0001) between the KITD816V mutation burden in blood and BM (74% concordant samples), but with a lower mean of KITD816V-mutated cells in blood (P = .0004) and a high rate of discordant BM+/blood− samples particularly among clonal MCAS (73%) and BM mastocytosis (51%), but also in cutaneous mastocytosis (9%), indolent SM (15%), and well-differentiated variants of indolent SM (7%). Purification of different compartments of blood-derived myeloid cells was done in 28 patients who were BM mast cell (MC)+/blood− for KITD816V, revealing KITD816V-mutated eosinophils (56%), basophils (25%), neutrophils (29%), and/or monocytes (31%) in most (61%) patients. Prognostically, the presence of ≥3.5% KITD816V-mutated cells (P < .0001) and an unstable KITD816V mutation cell burden (P < .0001) in blood and/or BM were both associated with a significantly shortened progression-free survival (PFS). [Conclusions]: These results confirm the high specificity but limited sensitivity of KITD816V analysis in whole blood for the diagnostic screening of SM and other primary MCAS, which might be overcome by assessing the mutation in blood-purified myeloid cell populations.This work was supported by grants from the Fundación Española de Mastocitosis (Madrid, Spain; grant number: FEM2021-SAM) and Blueprint Medicines Corporation (Cambridge, MA). PNN was supported by a grant of Government of Castilla y León (Orden EDU 875 2021), Spain; co-financed with the European Social Fund (BDNS (Identif.): 540787). We also thank the Agencia Estatal de Investigación (AEI) and European Regional Development Fund (FEDER) for the grant (EQC2019-005419-P) within the Subprograma Estatal de Infraestructuras de Investigación y Equipamiento Científico Técnico de 2019

Altered innate immune profile in blood of systemic mastocytosis patients

[Background]: Mast cells (MC) from systemic mastocytosis (SM) patients release MC mediators that lead to an altered microenvironment with potential consequences on innate immune cells, such as monocytes and dendritic cells (DC). Here we investigated the distribution and functional behaviour of different populations of blood monocytes and DC among distinct diagnostic subtypes of SM. [Methods]: Overall, we studied 115 SM patients - 45 bone marrow mastocytosis (BMM), 61 indolent SM (ISM), 9 aggressive SM (ASM)- and 32 healthy donors (HD). Spontaneous and in vitro-stimulated cytokine production by blood monocytes, and their plasma levels, together with the distribution of different subsets of blood monocytes and DCs, were investigated. [Results]: SM patients showed increased plasma levels and spontaneous production by blood monocytes of IL1β, IL6, IL8, TNFα and IL10, associated with an exhausted ability of LPS + IFNγ-stimulated blood monocytes to produce IL1β and TGFβ. SM (particularly ISM) patients also showed decreased counts of total monocytes, at the expense of intermediate monocytes and non-classical monocytes. Interestingly, while ISM and ASM patients had decreased numbers of plasmacytoid DC and myeloid DC (and their major subsets) in blood, an expansion of AXL+ DC was specifically encountered in BMM cases. [Conclusion]: These results demonstrate an altered distribution of blood monocytes and DC subsets in SM associated with constitutive activation of functionally impaired blood monocytes and increased plasma levels of a wide variety of inflammatory cytokines, reflecting broad activation of the innate immune response in mastocytosis.This study has been funded by Instituto de Salud Carlos III (ISCIII) (grant number PI19/01166; and Centro de Investigación Biomédica en Red de Cáncer [CIBERONC] programme, grant number CB16/12/00400) and co-funded by the European Union (EU). We thank the support of the Spanish National DNA Bank Carlos III (www.bancoadn.org; biobank ID B.0000716; supported by ISCIII and co-founded by EU [grant number PT20/00085]) for providing plasma samples. APP was supported by a grant of the Government of Castilla y León (Orden EDU/556/2019), Spain; co-financed with the “European Regional Development Fund” (BDNS, Identif.:422058). We thank the support of the Spanish Association of Mastocytosis and Related Diseases

Editorials

No abstract available

Options. Journal of the UNAB Financial Engineering Program. Volume 2 No. 3 January 2008

Empezando este nuevo siglo inicia labores la extensión del programa en San Gil, hoy ya se cuenta con cuatro cohortes graduadas. El 8 de mayo del 2001, se promulga el decreto 792 y posteriormente, el 29 de junio, el Decreto 1279 por medio de los cuales se establecieron los estándares de calidad para la creación, oferta y funcionamiento de programas académicos de pregrado en Ingeniería. Desde ese momento la Universidad organizó un equipo de trabajo con la finalidad de elaborar un documento en el que se muestre lo que la UNAB entiende como Ingeniería y cómo atiende a la formación de profesionales en este campo.¿Qué ha pasado en el nuevo siglo ? . - 4} Una nota sobre el cálculo del valor con endeudamiento constante . - 6 El mercado accionario en Colombia: Pruebas de eficiencia y aplicación de modelos en la estructuración de portafolios de inversión 14 “La competencia siempre produce perdedores..." 24 ¿En qué consiste analizar la incertidumbre en el cálculo de la reserva petrolera? 30 Instrumento novedoso de predicción en finanzas 34 Medición del riesgo en el mercado accionario colombiano explicado por variables exógenas 38 Cálculo yAnálisis de Betas para el Modelo CAPM 43 La toma de decisiones en las operaciones de exploración petrolera. 50 La brecha del desarrollo y la medida de la pobreza. 54Starting this new century, the extension of the program in San Gil begins work, today there are four graduate cohorts. On May 8, 2001, Decree 792 was enacted and later, on June 29, Decree 1279 by by means of which the quality standards for the creation, offer and operation of undergraduate academic programs in Engineering were established. From that moment on, the University organized a work team in order to prepare a document that shows what UNAB understands as Engineering and how it attends to the training of professionals in this field

The Caldera. No. 26

“La PALABRA tiene PODER”, más allá del lema que nos convocó en la décima versión del Concurso Inter colegiado de Oratoria, que en el marco de ULIBRO 2023, se llevó a cabo en NEOMUNDO, el 1 de septiembre pasado, esta frase es una profunda convicción que ha movido al Área de Lengua Castellana del Instituto Caldas, a propiciar y mantener este espacio en el que nuestros estudiantes son los protagonistas. Este año, al tratarse de una celebración especial, quisimos que el tema fundamental fuera el inmenso PODER que tiene la PALABRA; la palabra que construye, que transforma, que edifica, que fortalece, que acompaña, que “abriga”, a diario, al ser humano; en un mundo en el que se debe volver a entender y vivenciar, en el hogar, en la escuela, en la sociedad, el poder transformador de vocablos tan importantes como lo son: “Familia, Educación, Vida, Diversidad, Respeto, Literatura, Escritura, Creatividad, Lectura, Inclusión, Paz, Igualdad Social, Democracia, Ciudadanía y Diálogo”, la palabra cobró fuerza en las voces de nuestros educandos; de esta manera, analizar estos temas tiene que ver necesariamente con los “Futuros posibles”, que planteó la Gran Feria del Libro, ULIBRO, en su vigésima primera versión, para que sigamos trabajando por una sociedad mejor, razón de ser de todas las instituciones educativas del mundo entero.“The WORD has POWER”, beyond the motto that summoned us in the tenth version of the Intercollegiate Oratory Contest, which within the framework of ULIBRO 2023, was held in NEOMUNDO, last September 1, this phrase is a deep conviction that has moved the Spanish Language Area of ​​the Caldas Institute to promote and maintain this space in which our students are the protagonists. This year, as it is a special celebration, we wanted the fundamental theme to be the immense POWER that the WORD has; the word that builds, that transforms, that edifies, that strengthens, that accompanies, that “shelters”, daily, the human being; in a world in which we must understand and experience again, at home, at school, in society, the transformative power of words as important as: “Family, Education, Life, Diversity, Respect, Literature, Writing, Creativity, Reading, Inclusion, Peace, Social Equality, Democracy, Citizenship and Dialogue”, the word gained strength in the voices of our students; In this way, analyzing these issues necessarily has to do with the “Possible Futures”, which the Great Book Fair, ULIBRO, proposed in its twenty-first version, so that we continue working for a better society, the reason for being of all institutions. . educational institutions around the world.Modalidad Presencia

Jardins per a la salut

Facultat de Farmàcia, Universitat de Barcelona. Ensenyament: Grau de Farmàcia. Assignatura: Botànica farmacèutica. Curs: 2014-2015. Coordinadors: Joan Simon, Cèsar Blanché i Maria Bosch.Els materials que aquí es presenten són el recull de les fitxes botàniques de 128 espècies presents en el Jardí Ferran Soldevila de l’Edifici Històric de la UB. Els treballs han estat realitzats manera individual per part dels estudiants dels grups M-3 i T-1 de l’assignatura Botànica Farmacèutica durant els mesos de febrer a maig del curs 2014-15 com a resultat final del Projecte d’Innovació Docent «Jardins per a la salut: aprenentatge servei a Botànica farmacèutica» (codi 2014PID-UB/054). Tots els treballs s’han dut a terme a través de la plataforma de GoogleDocs i han estat tutoritzats pels professors de l’assignatura. L’objectiu principal de l’activitat ha estat fomentar l’aprenentatge autònom i col·laboratiu en Botànica farmacèutica. També s’ha pretès motivar els estudiants a través del retorn de part del seu esforç a la societat a través d’una experiència d’Aprenentatge-Servei, deixant disponible finalment el treball dels estudiants per a poder ser consultable a través d’una Web pública amb la possibilitat de poder-ho fer in-situ en el propi jardí mitjançant codis QR amb un smartphone

FULL Investiga Enero a Junio 2020 Número 1

Contiene: A propósito del coronavirus: pandemia o acontecimiento / Carol Fernandez Jaimes -- Desarrollo de nuevos materiales en el contexto de la IV Revolución Industrial y sus efectos en el COVID-19 / Jesús Manuel Gutiérrez Bernal -- El virus que coronó la vulnerabilidad de la formación remota en la educación Chilena y Colombiana” / Marcelo Palominos Bastias, Lupe García Cano y Víctor Martínez Gutiérrez -- Intuiciones psicosociales sobre la pandemia en el Siglo XXI / Rocío Venegas Luque -- Pensar la economía en tiempos de crisis / Oscar Esteban Morillo Martínez -- Acercamiento al concepto de educación superior en el marco normativo de la educación inclusiva en Colombia / Jose Escobar Romero -- Educación para la paz y la resiliencia en infancias vulneradas, fase II / Ana Dolores Gómez Romero -- Fútbol, de la mediatización global al lavado deportivo / Luis Francisco Buitrago -- Antea, proyecto de investigación que pone en reto a la comunicación como escenario para la transformación ambiental / Janneth Arley Palacios Chavarro -- Del desarrollo económico al desarrollo sos- tenible y el papel de la educación ambiental / Gloria Castaño-Camacho y Rosa Eugenia Reyes Gil -- Investigación en el ámbito turístico y gastronómico / Jesús Alexis Barón Chivara y Sandra Patricia Cote Daza -- Mercado de trabajo y empleabilidad de los profesionales en Colombia / Orlando Salinas Gómez -- El rol de la investigación contable en la academia y la sociedad / Paula Andrea Navarro Pérez -- Hacia la formación competitiva y de desarrollo empresarial / Melva Inés Gómez Caicedo y Diana Geraldine Jiménez García -- El comercio internacional como motor del crecimiento económico / José Vidal Castaño Ramírez -- Hacia el concepto transformacional de la educación superior inclusiva en el contexto colombiano / Castelblanco Daniela, Coronado Laura, Jiménez Wendy, Ocampo Yessica, Pachón Jose, Reyes María, Sánchez Vanesa -- La Inteligencia Artificial como quehacer investigativo y de formación al servicio de la humanidad en el seno del Semillero SofIA / Lucy Nohemy Medina Velandia -- “Un nuevo mundo”. Historieta ilustrada sobre el COVID-19 -- Camilo Rojas Zapata.Fundación Universitaria los Libertadore

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality